A Study of IPM514 in Patients With Esophageal Squamous Cell Carcinoma.

NCT07203898 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Esophageal Squamous Cell Carcinoma

Interventions

BIOLOGICAL: IPM514

Sponsor

Beijing Immupeutics Medicine Technology Limited